1 / 89

Drugs Used to Treat Infections

Drugs Used to Treat Infections. Chapter 5. Antimicrobials. Drugs used to prevent or treat infection caused by pathogens. Two Classifications. Bactericidal drugs kill bacteria directly Bacteriostatic drugs prevent bacteria from dividing . Infectious Disease.

emlyn
Download Presentation

Drugs Used to Treat Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drugs Used to Treat Infections Chapter 5

  2. Antimicrobials • Drugs used to prevent or treat infection caused by pathogens

  3. Two Classifications • Bactericidal drugs kill bacteria directly • Bacteriostatic drugs prevent bacteria from dividing

  4. Infectious Disease • Infections disease involves the presence of pathogen plus clinical signs and symptoms indicating infection. • Microorganisms spread by direct contact with infected person or contaminated hands, food, water, or objects.

  5. Common Bacterial Pathogens • Gram positive • Staphylococcus aureus • Streptocci • Enterococci • Gram negative • Escherichia coli or E-coli • Klebsiella • Proteus • Pseudomonas

  6. Streptococci • Part of the normal microbial flora of throat and nasopharynx • Common cause of pneumonia, otitis media (ear infection), sinusitis, and meningitis • Pneumococcal vaccination available for children / adults • Often follows a viral illness that injures the ciliated epithelium of respiratory tract

  7. Opportunistic Infections • Severe burns • Cancer • HIV • Indwelling IV catheter or urinary catheter • Corticosteroid therapy • Fungal or viral infections

  8. Laboratory Tests • Gram stain – microscopic identification of organism • Culture – identifies causative agent and susceptibility to specific antibiotics • Serology – titers or antibodies measured • CBC – looking at WBC

  9. Cultures • Throat • Wound • Urine • Sputum • Blood

  10. Clinical Pearl • Always collect culture: urine, sputum, wound drainage, or blood prior to starting antibiotic therapy. • If technician is drawing blood make sure it has been done before starting antibiotics.

  11. Two Types of Bacteria • Aerobic – grow and live in presence of oxygen • Staph & Strep • Anaerobic – cannot grow in presence of oxygen • Deep wounds • Characterized by abscess formation, foul-smelling pus and tissue destruction

  12. Community-Acquired Infection • Less severe and easier to treat, although drug resistant strains are increasing • Remember Staph is everywhere – it is normal flora on skin and in the upper respiratory tract • MRSA: methicillin-resistant-Staphylococcus aureus

  13. Nosocomial Infections • More severe and difficult to manage because they often result from drug-resistant microorganisms and occur in clients whose resistance is impaired • Pseudomonas • Proteus

  14. Bacterial Resistance • Bacteria develop the ability to produce substances which block the action of antibiotics or change their target or ability to penetrate the cells.

  15. What causes resistance? • Widespread use of antimicrobial drug • Interrupted or inadequate antimicrobial treatment of infection • Type of bacteria – gram-negative strains have higher rates of resistance • Re-occurring infections • Condition of the host • Location – critical care areas

  16. Host Defense Mechanisms • Skin • Mucous membranes • Secretions in GI, GU and respiratory tract • Coughing, swallowing, peristalsis • WBC – phagocytes – battling white cells • Elevated in the presence of infection

  17. Break-down of Natural Barriers • Breaks in skin, open lesions, prosthetic devices (total hip or knee) • Urinary catheters • Intravenous catheters • Impaired blood supply • Malnutrition • Poor personal and oral hygiene • Neonate / Geriatric

  18. Client History / Assessment • Allergies • Previous drug reactions • Baseline renal and liver function • Review culture reports for appropriate antibacterial drug choice • Patient response to antibiotics therapy • Are they getting better? • Any side effects?

  19. Drug Selection • Empiric therapy – antibiotics may need to be started before the organism is identified • Cultures take 48 to 72 hours • A single broad spectrum may be used to cover suspected organism

  20. Switching Antibiotics • If cultures indicate a specific antibiotic • If the infection is not getting better

  21. Cost • Designer drugs are more expensive • Generic brands may work just as well

  22. Beta-Lactam Antibacterials Chapter 30

  23. Penicillin • First generation IM or IV • Newer penicillins have been developed that increase gastric acid stability of penicillin • Good drug since it enters most bodily fluids: joint, pleural, and pericardial. • Not effective against intraocular (eye) or cerebral spinal fluid infection (CNS)

  24. Penicillin • Bactericidal action against sensitive bacteria • Action: binds to bacterial wall, resulting in cell death

  25. Nursing Implications • Vital signs • Review lab values especially culture results • Ask about previous drug reactions or allergies • Observe for allergic reaction • IM or IV may occur within 20 to 30 minutes after administration • PO may occur in a few days

  26. Client Teaching • Take around the clock as ordered • Observe for super-infections: vaginal discharge, diarrhea, rash or allergic reaction • Call MD is fever persists after 24 to 36 hours.

  27. Ampicillin – Synthetic Penicillin • Broad spectrum effective against several gram-positive and gram-negative bacteria • E-coli, proteus, Salmonella, Shigella • Not effective against staphylococci on gonococci • Bronchitis, sinusitis, and otitis media

  28. Ampicillin • Bactericidal action – spectrum is broader than penicillin • Binds to bacterial wall resulting in cell death

  29. Nursing Implications • Same as penicillin • Ask client about oral contraceptive use – drug may cause transient decrease in effectiveness • Advise to use additional BC – barrier protection during antibiotic therapy

  30. Amoxicillin • Oral equivalent of Ampicillin • Readily absorbed and reaches therapeutic levels rapidly • Drug of choice in prevention of bacterial endocarditis • Clients with total knee or hip replacement, heart valve replacement need to take prior to any dental work, endoscopy exams

  31. Amoxicillin • Action: binds to bacterial cell wall causing cell death. • Therapeutic effects: bactericidal action • Spectrum is broader than penicillin • Well absorbed from duodenum • More resistant to acid inactivation than other penicillins

  32. Nursing implication / client teaching • Same as penicillin • Instruct female clients taking oral contraceptives to use an alternate or additional non-hormonal method of contraception during antibiotic therapy

  33. Dosing for Amoxicillin • Adults: 250 to 500 mg q8h • Infants and children less than 20 kg: • 20 – 40 mg / kg / day divided into doses q 8 hours

  34. Cephalosporins • Widely used drug derived from fungus • Used against gram–negative bacteria • Widely absorbed and distributed in most bodily fluids – placenta and breast milk • First generation Cephalosporin drugs do not reach therapeutic levels in CNS but 2nd, and 3rd generation drugs do – especially important in treating meningitis

  35. First Generation Cephalosporins • Not used very much since better drugs have been developed • Bactericidal action – binds to bacterial cell wall, causing cell death • Keflex (PO) still used extensively in treatment of skin infections • Ancef – often ordered preoperatively

  36. Keflex • First generation cephalosporin • Action: binds to bacterial cell wall membrane, causing cell death • Therapeutic effect: bactericidal action against susceptible bacteria • Active against many gram-positive cocci – step and staph

  37. Client teaching • May be taken with or without food but food may minimize the GI irritation • Distribution: may cross placenta or enter breast milk in low concentrations. • Excreted entirely by the kidneys.

  38. Keflex Dosing • Adults: 250 – 500 mg q 6 hours • Children: 25 – 50 mg / kg / day in divided doses q 6 h

  39. Cefazolin or Ancef • Cefazolin – first generation cephalosporin • Well absorbed following IM or IV administration • Crosses to placenta and breast milk in small concentrations • Minimal CSF penetration • Excreted by kidneys

  40. Ancef Dosing • IV • Used for UTI, bone and skin infections, endocarditis • Not suitable for treatment of meningitis • Perioperative prophylaxis – 1 gram within 60 minutes of incision and than every 8 hours for 24 hours

  41. Second-Generation Cephalosporins • More active against some gram-negative organisms and anaerobic organisms than the first generation drugs. • May be effective in infections resistant to other antibiotics • Penetration into CSF is poor but adequate to be used in meningitis • Action: bactericidal – binds to cell wall

  42. Ceclor • PO Cephalosporin: • Adult: 250 – 500 mg q 8 h • Children: 20 - 40 mg/kg/d in 3 divided doses

  43. Practice Problem • 22 pound child • Minimal dose of 20 mg per kg • Given q 8 hours • 22 pounds to kilogram = 10 kg • 20 mg x 10 kg = 200 mg po q day • 200 divided by 3 = 66 mg / dose

  44. Cefuroxime • UTI (urinary tract infection), otitis media (ear infection), pharyngitis (throat infection) or URI (upper respiratory infection) • Meningitis

  45. Cefuroxime • PO • Adults – 250 to 500 mg every 12 hours • Children – 15 mg / kg / q 12 hours • IM or IV • Adults – 1.5 grams every 12 hours • Children – • 16.7 – 33.3 mg / kg / q 8 hours • 15 – 50 mg / kg / q 12 hours

  46. Second – Generation Cephalosporin • Cefuroxime: penetrates cerebrospinal fluid in presence of inflamed meninges • Bacterial meningitis: 200 to 240 mg / kg / d in divided doses reduced to 100 mg / kg / dose • Moderate infections: • > 3 months 50 to 100 mg / kg / d in 3 divided doses

  47. Third – Generation Cephalosporins • Extended protection against gram-negative organisms • Used against some resistant organisms to the first and second generation Cephalosporins • Increased activity against – Enterobacter, Haemophilus influenza, E. Coli

  48. Cephalosporins • Third – Generation: Claforan – serious infections resistant organisms – E. Coli, Proteus, Klebsiella • Fourth – Generation: only used if organism resistant

  49. Aminoglycosides and Fluoroquinolones Chapter 31

  50. Aminoglycosides • Bactericidal action – inhibits protein synthesis at level of 302 ribosome • Treatment of serious gram-negative bacilli and infections caused by staphylococci when penicillin or less toxic drugs are contraindicated

More Related